Long-term management & prevention of reflux oesophagitis relapse. Prevention of nonselective NSAID-induced gastroduodenal ulcers in patients at risk w/ need for continuous NSAID treatment. 40 mg: H pylori eradication in patients w/ peptic ulcers. 40 mg, inj: Duodenal & gastric ulcer. Moderate & severe reflux esophagitis. Zollinger-Ellison syndrome & other pathological hypersecretory conditions.